This study is in progress, not accepting new patients
An Investigational Immuno-therapy Study to Evaluate Safety and Effectiveness in Patients With Melanoma That Has Spread to the Brain, Treated With Nivolumab in Combination With Ipilimumab, Followed by Nivolumab by Itself
Melanoma Nivolumab Ipilimumab Nivolumab and Ipilimumab
Lead Scientist at UCSF
- Alain Algazi
Associate Professor, Medicine. Authored (or co-authored) 60 research publications.